Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
Recruiting now · Not applicable
Conditions studied: COPD
In brief
This study aims to assess whether to describe the effects of the administration of nasal high flow (NHF) at 70 liters per minute (L/min) in a 6-Minute Walk Test (6-MWT) among Chronic Obstructive Pulmonary Disease (COPD) patients and to characterize the association between self-reported dyspnea with and without NHF at 70 L/min following a 6-MWT.
Key facts
- Study ID
- NCT06578156
- Run by
- University of Miami
- People needed
- 45
- Starts
- 2024-12-12
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-06-22
Who can join
Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Able to consent
- Age 18 years or older
- Diagnosis of COPD
- Ability to ambulate without assistance
- Use of low-flow nasal cannula ≤ 4 L/min or no supplemental oxygen (O2) at all
You may not qualify if…
- Pregnancy
- Being on bedrest
- Inability to consent or cooperate with the study
- Using of > 4 L/min of supplemental O2 or requiring non-invasive ventilation during the daytime
- Hemodynamic instability (resting heart rate > 130/minute, systolic blood pressure of ≤ 90 mmHg or ≥ 180 mmHg)
- Metal implants in the thoracic regions (pacemakers, Automatic Implantable Cardioverter Defibrillator (AICD), plates, screws, rods, and disc replacements)
Where it is running
- University of Miami — Miami, Florida, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.